Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results Share SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended September 30, 2025. Visit the Events and Presentations page of the Investor Relations section under the "Company†tab at www.twistbioscience.com to view the detailed fiscal ...